165 related articles for article (PubMed ID: 4270059)
1. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
Oakley GP
JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
[No Abstract] [Full Text] [Related]
2. Warning on diiodohydroxyquin.
Med Lett Drugs Ther; 1974 Aug; 16(17):71-2. PubMed ID: 4276320
[No Abstract] [Full Text] [Related]
3. Subacute myelo-optic neuropathy and the halogenated hydroxyquinolines.
Med J Aust; 1971 Nov; 2(21):1090-1. PubMed ID: 5127493
[No Abstract] [Full Text] [Related]
4. [The history of quinolines].
Wolffers I
Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
[No Abstract] [Full Text] [Related]
5. Subacute myelo-optico-neuropathy (SMON).
Nelson E
Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
[No Abstract] [Full Text] [Related]
6. Idiosyncratic neurotoxicity: clioquinol and bismuth.
Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
[No Abstract] [Full Text] [Related]
7. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
8. [Subacute myelo-optico neuropathy (author's transl)].
Heilig P; Thaler A
Klin Monbl Augenheilkd; 1974 Mar; 164(3):386-8. PubMed ID: 4277280
[No Abstract] [Full Text] [Related]
9. Myelopathy after clioquinol treatment.
Osterman PO
Lancet; 1971 Sep; 2(7723):544. PubMed ID: 4105685
[No Abstract] [Full Text] [Related]
10. Peripheral neuropathy in rats fed with clioquinol.
Jones EL; Searle CE; Smith WT
J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
[No Abstract] [Full Text] [Related]
11. [SMON-- Japanese disease?].
Dölle W
Internist (Berl); 1971 Sep; 12(9):405-6. PubMed ID: 4938935
[No Abstract] [Full Text] [Related]
12. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
Nakae K; Yamamoto S; Shigematsu I; Kono R
Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
[No Abstract] [Full Text] [Related]
13. Neurotoxicity of oxyquinolines.
Hansson O; Herxheimer A
Lancet; 1980 Jun; 1(8180):1253-4. PubMed ID: 6104069
[No Abstract] [Full Text] [Related]
14. Clioquinol: time to act.
de Pinto O; Burley D
Lancet; 1977 Jun; 1(8024):1256. PubMed ID: 68347
[No Abstract] [Full Text] [Related]
15. [Pathological findings in chronic poisoning with Chinoform in dogs].
Tateishi J; Ikeda H; Saito A; Kuroda S; Hayabara T
Shinkei Kenkyu No Shimpo; 1972 Jun; 16(3):477-82. PubMed ID: 5066190
[No Abstract] [Full Text] [Related]
16. Subacute myelo-optic neuropathy in Australia.
Selby G
Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
[No Abstract] [Full Text] [Related]
17. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
Tjälve H
Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of clioquinol in laboratory animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117427
[No Abstract] [Full Text] [Related]
19. [SMON and chinoform: search for the causative agent].
Tsubaki T; Honma Y; Hoshi M
Naika; 1971; 28(3):451-5. PubMed ID: 5097705
[No Abstract] [Full Text] [Related]
20. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
